BR0308984A - Formulações em pó adequadas para inalação - Google Patents

Formulações em pó adequadas para inalação

Info

Publication number
BR0308984A
BR0308984A BR0308984-3A BR0308984A BR0308984A BR 0308984 A BR0308984 A BR 0308984A BR 0308984 A BR0308984 A BR 0308984A BR 0308984 A BR0308984 A BR 0308984A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
physiologically acceptable
acceptable excipient
tiotropium salt
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0308984-3A
Other languages
English (en)
Inventor
Rolf Banholzer
Manfred Graulich
Christian Kulinna
Andreas Mathes
Helmut Meissner
Peter Sieger
Peter Specht
Michael Trunk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BR0308984A publication Critical patent/BR0308984A/pt
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Abstract

"FORMULAçõES EM Pó ADEQUADAS PARA INALAçãO". A presente invenção refere-se a preparações em forma de pó que contem tiotrópio para inalação, a processos para a preparação das mesmas bem como o uso das mesmas para a preparação de uma composição farmacêutica para o tratamento de queixas com relação à respiração, de forma específica para o tratamento de COPD (doença pulmonar obstrutiva crónica) e asma.
BR0308984-3A 2002-04-04 2003-03-28 Formulações em pó adequadas para inalação Pending BR0308984A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007634 2002-04-04
PCT/EP2003/003253 WO2003084509A1 (en) 2002-04-04 2003-03-28 Powder formulations suitable for inhalation

Publications (1)

Publication Number Publication Date
BR0308984A true BR0308984A (pt) 2005-02-09

Family

ID=28685839

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308984-3A Pending BR0308984A (pt) 2002-04-04 2003-03-28 Formulações em pó adequadas para inalação

Country Status (20)

Country Link
US (2) US6881422B2 (pt)
EP (1) EP1494648B1 (pt)
JP (1) JP2005526103A (pt)
KR (1) KR101007151B1 (pt)
CN (1) CN100360116C (pt)
AT (1) ATE339951T1 (pt)
AU (1) AU2003221531B2 (pt)
BR (1) BR0308984A (pt)
CA (1) CA2479919C (pt)
DE (1) DE60308497T2 (pt)
DK (1) DK1494648T3 (pt)
ES (1) ES2272968T3 (pt)
HK (1) HK1078795A1 (pt)
IL (2) IL163736A0 (pt)
MX (1) MXPA04009583A (pt)
NZ (1) NZ536277A (pt)
PL (1) PL207752B1 (pt)
RU (1) RU2004132222A (pt)
WO (1) WO2003084509A1 (pt)
ZA (1) ZA200406911B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2227268T3 (es) * 2000-10-12 2005-04-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Nuevos polvos para inhalacion con contenido en tiotropio.
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PT1682541E (pt) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) * 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE19515625C2 (de) * 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
EP1862164A3 (de) * 1998-11-13 2012-12-26 Jagotec AG Trockenpulver zur Inhalation
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
ES2227268T3 (es) * 2000-10-12 2005-04-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Nuevos polvos para inhalacion con contenido en tiotropio.
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6482429B1 (en) * 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern

Also Published As

Publication number Publication date
ES2272968T3 (es) 2007-05-01
US20040029907A1 (en) 2004-02-12
AU2003221531A1 (en) 2003-10-20
MXPA04009583A (es) 2005-01-11
CN100360116C (zh) 2008-01-09
CA2479919A1 (en) 2003-10-16
US6881422B2 (en) 2005-04-19
JP2005526103A (ja) 2005-09-02
NZ536277A (en) 2006-03-31
EP1494648B1 (en) 2006-09-20
DK1494648T3 (da) 2006-12-27
DE60308497D1 (de) 2006-11-02
PL207752B1 (pl) 2011-01-31
CN1646099A (zh) 2005-07-27
WO2003084509A1 (en) 2003-10-16
RU2004132222A (ru) 2005-10-10
HK1078795A1 (en) 2006-03-24
CA2479919C (en) 2011-05-17
IL163736A0 (en) 2005-12-18
EP1494648A1 (en) 2005-01-12
US20050009857A1 (en) 2005-01-13
ZA200406911B (en) 2006-07-26
PL371267A1 (en) 2005-06-13
DE60308497T2 (de) 2007-02-22
ATE339951T1 (de) 2006-10-15
KR101007151B1 (ko) 2011-01-13
AU2003221531B2 (en) 2008-10-23
IL163736A (en) 2010-12-30
KR20040098049A (ko) 2004-11-18

Similar Documents

Publication Publication Date Title
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
JP2007520507A5 (pt)
RU2006132036A (ru) Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей
BRPI0508170A (pt) formulações farmacêuticas para inaladores de pó seco, que compreendem um ingrediente ativo de potência de baixa dosagem
ME00077B (me) Formoterol najfiniji preparat
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
NO20061441L (no) Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
HK1078795A1 (en) Powder formulations suitable for inhalation
NO20053090L (no) Pulverformulering for innhalering inneholdende tiotropium.
RS20060292A (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
WO2005077338A8 (en) Particles for inhalation rapid release properties
JP2006502961A (ja) フィルム錠剤製造用リバビリン顆粒

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.